Fuller & Thaler Asset Management
KIN

Fuller & Thaler Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Fuller & Thaler Asset Management’s Portfolio KIN Stock Details KIN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
2019
Q2 		$1.27M Sell
2019
Q1 		$1.41M Sell
2018
Q4 		$1.71M Buy